Research from INSERM provides new data about breast cancer.(Report)

Research findings, 'Anti-HER2 vaccines: new prospects for breast cancer therapy,' are discussed in a new report. According to a study from Montpellier, France, "Each year, breast cancer accounts for more than 400,000 new cancer cases and more than 130,000 cancer deaths in Europe. Prognosis of nonmetastatic breast cancer patients is directly related to the extent of the disease, mainly nodal spreading and tumor size, and to the molecular profile, particularly HER2 over-expression."

"In patients with HER2-over-expressing tumors, different studies have shown cellular and/or humoral immune responses against HER2 associated with a lower tumor development at early stages of the …